QT
FLXN

Quantbot Technologies’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Quantbot Technologies’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-188
Closed -$2K – 1894
2020
Q4 		$2K Sell
188
-272
-59% -$3.16K ﹤0.01% 1209
2020
Q3 		$4K Buy
+460
New +$5.64K ﹤0.01% 1206
2020
Q2 		– Sell
-387
Closed -$3K – 1551
2020
Q1 		$3K Sell
387
-4,872
-93% -$73.4K ﹤0.01% 791
2019
Q4 		$108K Buy
+5,259
New +$88.7K 0.01% 805
2018
Q4 		– Sell
-501
Closed -$9K – 1561
2018
Q3 		$9K Buy
+501
New +$11.5K ﹤0.01% 1178
2018
Q2 		– Sell
-1,401
Closed -$31K – 1609
2018
Q1 		$31K Buy
1,401
+1,212
+641% +$29.6K ﹤0.01% 1029
2017
Q4 		$4K Buy
+189
New +$4.63K ﹤0.01% 1135
2017
Q2 		– Sell
-390
Closed -$10K – 1482
2017
Q1 		$10K Sell
390
-828
-68% -$16.9K ﹤0.01% 1055
2016
Q4 		$23K Buy
+1,218
New +$23.3K ﹤0.01% 921

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Quantbot Technologies's FLXN Position: Q1 2021 in Review

Quantbot Technologies sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2021, closing a stake of 188 shares — an estimated $2K sold.

Quantbot Technologies first reported a position in FLXN in Q4 2016 and held it in 9 quarters. The position peaked at $108K in Q4 2019. 145 funds tracked by Wall St. Rank hold FLXN as of Q1 2021.

  • Quantbot Technologies reported no remaining Flexion Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Quantbot Technologies sold 188 Flexion Therapeutics, Inc. shares in Q1 2021, an estimated $2K.
  • Quantbot Technologies first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 9 quarters.
  • Quantbot Technologies's Flexion Therapeutics, Inc. position peaked at $108K in Q4 2019.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2021.

Based on Quantbot Technologies's 13F filing for Q1 2021, filed 14 May 2021.